JP2024535009A5 - - Google Patents

Info

Publication number
JP2024535009A5
JP2024535009A5 JP2024515936A JP2024515936A JP2024535009A5 JP 2024535009 A5 JP2024535009 A5 JP 2024535009A5 JP 2024515936 A JP2024515936 A JP 2024515936A JP 2024515936 A JP2024515936 A JP 2024515936A JP 2024535009 A5 JP2024535009 A5 JP 2024535009A5
Authority
JP
Japan
Prior art keywords
dose
months
nircevimab
rsv
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024515936A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024535009A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/076311 external-priority patent/WO2023039584A2/en
Publication of JP2024535009A publication Critical patent/JP2024535009A/ja
Publication of JP2024535009A5 publication Critical patent/JP2024535009A5/ja
Pending legal-status Critical Current

Links

JP2024515936A 2021-09-13 2022-09-12 ニルセビマブによる呼吸器合胞体ウイルス下気道感染の予防 Pending JP2024535009A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202163261117P 2021-09-13 2021-09-13
US63/261,117 2021-09-13
US202263266594P 2022-01-10 2022-01-10
US63/266,594 2022-01-10
US202263363633P 2022-04-26 2022-04-26
US63/363,633 2022-04-26
US202263364554P 2022-05-11 2022-05-11
US63/364,554 2022-05-11
PCT/US2022/076311 WO2023039584A2 (en) 2021-09-13 2022-09-12 Prevention of respiratory syncytial virus lower respiratory tract infection with nirsevimab

Publications (2)

Publication Number Publication Date
JP2024535009A JP2024535009A (ja) 2024-09-26
JP2024535009A5 true JP2024535009A5 (cg-RX-API-DMAC7.html) 2025-09-26

Family

ID=83508746

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024515936A Pending JP2024535009A (ja) 2021-09-13 2022-09-12 ニルセビマブによる呼吸器合胞体ウイルス下気道感染の予防

Country Status (9)

Country Link
US (1) US20250340622A1 (cg-RX-API-DMAC7.html)
EP (1) EP4402166A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024535009A (cg-RX-API-DMAC7.html)
KR (1) KR20240055097A (cg-RX-API-DMAC7.html)
AU (1) AU2022341188A1 (cg-RX-API-DMAC7.html)
CA (1) CA3229901A1 (cg-RX-API-DMAC7.html)
IL (1) IL310974A (cg-RX-API-DMAC7.html)
TW (1) TW202340237A (cg-RX-API-DMAC7.html)
WO (1) WO2023039584A2 (cg-RX-API-DMAC7.html)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS60387B1 (sr) 2014-01-15 2020-07-31 Medimmune Llc Rsv-specifična antitela i njihovi funkcionalni delovi
US12024553B2 (en) * 2019-04-30 2024-07-02 Medimmune Limited Dosage regimens for and compositions including anti-RSV antibodies

Similar Documents

Publication Publication Date Title
JP2020002144A (ja) 小児における急性呼吸促迫症候群の治療のための吸入一酸化窒素ガスを使用する方法
Tal et al. Methylprednisolone therapy for acute asthma in infants and toddlers: a controlled clinical trial
Wang et al. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia
BERGEN Appetite stimulating properties of cyproheptadine
US20230201497A1 (en) Method for pulsatile delivery of a gaseous drug
JP2025510369A5 (cg-RX-API-DMAC7.html)
JPH05170647A (ja) 睡眠中の換気を改善する方法および睡眠に係る換気異常を処置する方法
CN114504578A (zh) 治疗、预防由病毒感染引起的相关疾病的药物及其用途
JP2022531205A5 (cg-RX-API-DMAC7.html)
Takiguchi et al. Fulminant Mycoplasma pneumoniae pneumonia
Zielecki et al. Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab
Sandritter et al. Respiratory syncytial virus-immunoglobulin intravenous (RSV-IGIV) for respiratory syncytial viral infections: part I
JP2019504040A (ja) 中等度〜重度のインフルエンザの処置
Bentlin et al. Sildenafil for pulmonary hypertension treatment after cardiac surgery
BR112020010878A2 (pt) tratamento de rsv com produto de combinação
Miledge et al. Instructive Case Pneumocystis carinii pneumonia as a presenting feature of X-linked hyper-IgM syndrome.
TW202245799A (zh) 治療冠狀病毒感染及由其導致之發炎所誘發的肺損傷之方法
JP2023533658A5 (cg-RX-API-DMAC7.html)
EP3324993A1 (en) Composition for treatment of rsv
Wada et al. Respiratory failure of Williams-Campbell syndrome is effectively treated by noninvasive positive pressure ventilation
Alaoui-Inboui et al. Mortality Associated With Viral Bronchiolitis in a Pediatric Department: A Retrospective Analysis
Idle et al. Treatment of angina pectoris with nifedipine
Tungal et al. 7 Acute Bronchiolitis
Jugulete et al. Severe form of COVID-19 in a neonate with resuscitated cardio-respiratory arrest-Case presentation
Raitakari et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood